Tercica, Inc.

Tercica, Inc. - 651 Gateway Blvd., Suite 950, South San Francisco, CA 94080-7111; acquired by Ipsen S.A. in 2008

Related product monographs:

1. Insulin-like Growth Factor-1, rDNA/Tercica -- R&D ; Tech.
2. Insulin-like Growth Factor-1/IGFBP-3, rDNA -- Patent dispute
3. Botulinum Toxin A/Ipsen -- USA mark.

Location - South San Francisco CA 94080 USA

Further information:
Description, ordering information, etc.
Order/Inquiry
Products Database

Copyright ©2020. Biotechnology Information Institute